Perivascular dexamethasone

COMBINATION_PRODUCT2 trials

Sponsors

Mercator MedSystems, Inc.

Conditions

Iliofemoral; ThrombosisThrombosis, Deep Vein

Phase 2

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Active, not recruitingNCT04858776

Mercator MedSystems, Inc.Iliofemoral; Thrombosis

Start: 2022-08-08End: 2027-05-31Target: 60Updated: 2026-06-25

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

RecruitingNCT04862468

Mercator MedSystems, Inc.Iliofemoral; Thrombosis, Thrombosis, Deep Vein

Start: 2021-10-29End: 2028-02-01Target: 80Updated: 2025-07-04